SCM
CDLX icon

Sterling Capital Management’s Cardlytics CDLX Stock Holding History

Sterling Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$75 – 3288
2025
Q1 		$75 Hold
4
– – ﹤0.01% 3162
2024
Q4 		$152 Hold
4
– – ﹤0.01% 3144
2024
Q3 		$131 Buy
+4
New +$222 ﹤0.01% 3161

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Sterling Capital Management's CDLX Position: Q2 2025 in Review

Sterling Capital Management sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 4 shares — an estimated $75 sold.

Sterling Capital Management first reported a position in CDLX in Q3 2024 and held it in 3 quarters. The position peaked at $152 in Q4 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Sterling Capital Management reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 4 Cardlytics shares in Q2 2025, an estimated $75.
  • Sterling Capital Management first reported a position in Cardlytics in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Cardlytics position peaked at $152 in Q4 2024.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.